These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 11388612)

  • 1. A dietary probiotic (Bifidobacterium lactis HN019) reduces the severity of Escherichia coli O157:H7 infection in mice.
    Shu Q; Gill HS
    Med Microbiol Immunol; 2001 Apr; 189(3):147-52. PubMed ID: 11388612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune protection mediated by the probiotic Lactobacillus rhamnosus HN001 (DR20) against Escherichia coli O157:H7 infection in mice.
    Shu Q; Gill HS
    FEMS Immunol Med Microbiol; 2002 Sep; 34(1):59-64. PubMed ID: 12208607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Bifidobacterium thermacidophilum probiotic feeding on enterohemorrhagic Escherichia coli O157:H7 infection in BALB/c mice.
    Gagnon M; Kheadr EE; Dabour N; Richard D; Fliss I
    Int J Food Microbiol; 2006 Aug; 111(1):26-33. PubMed ID: 16822570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probiotic treatment using Bifidobacterium lactis HN019 reduces weanling diarrhea associated with rotavirus and Escherichia coli infection in a piglet model.
    Shu Q; Qu F; Gill HS
    J Pediatr Gastroenterol Nutr; 2001 Aug; 33(2):171-7. PubMed ID: 11568519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary Bifidobacterium lactis (HN019) enhances resistance to oral Salmonella typhimurium infection in mice.
    Shu Q; Lin H; Rutherfurd KJ; Fenwick SG; Prasad J; Gopal PK; Gill HS
    Microbiol Immunol; 2000; 44(4):213-22. PubMed ID: 10832963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The study for the immuno-protection of E. coli O157:H7 outer membrane protein].
    Zhang Y; Lu SQ; Zhang YZ; Zhao BX; Xu JG
    Zhonghua Yi Xue Za Zhi; 2004 Jan; 84(1):58-62. PubMed ID: 14990161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of immunity in the elderly by dietary supplementation with the probiotic Bifidobacterium lactis HN019.
    Gill HS; Rutherfurd KJ; Cross ML; Gopal PK
    Am J Clin Nutr; 2001 Dec; 74(6):833-9. PubMed ID: 11722966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune-stimulating properties of 80% methanolic extract of Ludwigia octovalvis against Shiga toxin-producing E. coli O157:H7 in Balb/c mice following experimental infection.
    Kadum Yakob H; Manaf Uyub A; Fariza Sulaiman S
    J Ethnopharmacol; 2015 Aug; 172():30-7. PubMed ID: 26091966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of Escherichia coli O157:H7 infection in gnotobiotic mice associated with Bifidobacterium strains.
    Yoshimura K; Matsui T; Itoh K
    Antonie Van Leeuwenhoek; 2010 Feb; 97(2):107-17. PubMed ID: 19911297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of a humoral immune response following an Escherichia coli O157:H7 infection with an immunomodulatory peptidic fraction derived from Lactobacillus helveticus-fermented milk.
    Leblanc J; Fliss I; Matar C
    Clin Diagn Lab Immunol; 2004 Nov; 11(6):1171-81. PubMed ID: 15539524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal immunization with novel EspA-Tir-M fusion protein induces protective immunity against enterohemorrhagic Escherichia coli O157:H7 challenge in mice.
    Lin R; Zhu B; Zhang Y; Bai Y; Zhi F; Long B; Li Y; Wu Y; Wu X; Fan H
    Microb Pathog; 2017 Apr; 105():19-24. PubMed ID: 28163157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunostimulatory probiotic Lactobacillus rhamnosus HN001 and Bifidobacterium lactis HN019 do not induce pathological inflammation in mouse model of experimental autoimmune thyroiditis.
    Zhou JS; Gill HS
    Int J Food Microbiol; 2005 Aug; 103(1):97-104. PubMed ID: 16084270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of immunoglobulin enriched bovine colostrum against oral challenge with enterohaemorrhagic Escherichia coli O157:H7 in mice.
    Funatogawa K; Ide T; Kirikae F; Saruta K; Nakano M; Kirikae T
    Microbiol Immunol; 2002; 46(11):761-6. PubMed ID: 12516772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B-cell epitope KT-12 of enterohemorrhagic Escherichia coli O157:H7: a novel peptide vaccine candidate.
    Wan CS; Zhou Y; Yu Y; Peng LJ; Zhao W; Zheng XL
    Microbiol Immunol; 2011 Apr; 55(4):247-53. PubMed ID: 21272063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isotype-specific antibody responses against Escherichia coli O157:H7 locus of enterocyte effacement proteins in adult beef cattle following experimental infection.
    Bretschneider G; Berberov EM; Moxley RA
    Vet Immunol Immunopathol; 2007 Aug; 118(3-4):229-38. PubMed ID: 17617472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefits of Bifidobacterium animalis subsp. lactis Probiotic in Experimental Periodontitis.
    Oliveira LF; Salvador SL; Silva PH; Furlaneto FA; Figueiredo L; Casarin R; Ervolino E; Palioto DB; Souza SL; Taba M; Novaes AB; Messora MR
    J Periodontol; 2017 Feb; 88(2):197-208. PubMed ID: 27660886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a dual vaccine for prevention of Brucella abortus infection and Escherichia coli O157:H7 intestinal colonization.
    Iannino F; Herrmann CK; Roset MS; Briones G
    Vaccine; 2015 May; 33(19):2248-2253. PubMed ID: 25820069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bifidobacterium animalis subsp lactis HN019 presents antimicrobial potential against periodontopathogens and modulates the immunological response of oral mucosa in periodontitis patients.
    Invernici MM; Furlaneto FAC; Salvador SL; Ouwehand AC; Salminen S; Mantziari A; Vinderola G; Ervolino E; Santana SI; Silva PHF; Messora MR
    PLoS One; 2020; 15(9):e0238425. PubMed ID: 32960889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of four probiotic strains and Escherichia coli O157:H7 on tight junction integrity and cyclo-oxygenase expression.
    Putaala H; Salusjärvi T; Nordström M; Saarinen M; Ouwehand AC; Bech Hansen E; Rautonen N
    Res Microbiol; 2008; 159(9-10):692-8. PubMed ID: 18783733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutralizing activity of bovine colostral antibody against verotoxin derived from enterohemorrhagic Escherichia coli O157:H7 in mice.
    Kuribayashi T; Seita T; Fukuyama M; Furuhata K; Honda M; Matsumoto M; Seguchi H; Yamamoto S
    J Infect Chemother; 2006 Oct; 12(5):251-6. PubMed ID: 17109087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.